Literature DB >> 17621248

Frequent douching and clinical outcomes among HIV-infected women.

Rebecca A Clark1, Katherine P Theall, Angela M Amedee, Patricia J Kissinger.   

Abstract

OBJECTIVE: To determine the prevalence of douching among a cohort of HIV-infected women and to examine clinical outcomes associated with frequent douching-namely bacterial vaginosis, presence of a sexually-transmitted infections, and genital tract HIV-1 RNA shedding. STUDY
DESIGN: Participants included a concurrent cohort of 187 women attending an HIV outpatient clinic in New Orleans, LA. Subjects underwent clinical examinations and answered questions in a computer-assisted survey at each visit.
RESULTS: At baseline, 1-, and 3-month follow-ups, 64.2%, 56.5%, and 54.7% of women, respectively, indicated that they douched. In multivariable analyses, douching >1 time a month was independently associated with the outcomes of bacterial vaginosis and presence of a selected sexually transmitted infection (Trichomonas vaginalis, Neisseria gonorrhea, or Chlamydia trachomatis). Although not significant, women who douched >1 time a month were also twice as likely to have genital tract HIV-1 RNA shedding as nondouchers.
CONCLUSIONS: This is the first study performed in women infected with HIV to link a significant dose-response relationship between douching and the clinical outcomes of bacterial vaginosis and presence of a sexually transmitted infection, and to examine the association between douching and genital tract HIV-1 RNA shedding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621248     DOI: 10.1097/OLQ.0b013e31811ec7cb

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  16 in total

1.  Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota.

Authors:  Caroline Mitchell; Jane Hitti; Kathleen Paul; Kathy Agnew; Susan E Cohn; Amneris E Luque; Robert Coombs
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

2.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

3.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

4.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

5.  Determinants of HIV shedding in the lower genital tract of women.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 6.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

7.  Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Authors:  Anna Gibbs; Taha Hirbod; Qingsheng Li; Karin Bohman; Terry B Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani; Kristina Broliden; Annelie Tjernlund
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

8.  Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Megan Gatski; David H Martin; Rebecca A Clark; Emily Harville; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

9.  New concepts in the etiology of bacterial vaginosis.

Authors:  Jane R Schwebke
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

10.  The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Alys Adamski; Rebecca A Clark; Leandro Mena; Harold Henderson; Judy Levison; Norine Schmidt; Hirut T Gebrekristos; David H Martin; Patricia Kissinger
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.